Promising Results in Early Trial of Novel MS Treatment

Reporting in the journal Science Translational Medicine, researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe. Study co-author Stephen D. Miller, of Northwestern University, describes the novel approach tested in this small, phase 1 clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type 1 diabetes.